Myopia Control Spectacle Lens Cessation Study

Running, not enrolling · Not applicable

Conditions studied: Myopia, Myopia Progression, Juvenile Myopia

In brief

To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses. To quantify axial length progression following cessation of use of specific spectacle lenses.

Key facts

Study ID

NCT05893979

Run by

SightGlass Vision, Inc.

People needed

90

Starts

2023-06-23

Expected to finish

2027-07-31

Last updated by the study team

2026-05-05

Who can join

Age: 9 and older, up to 16. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Previously a successfully completed participant in the CYPRESS Extension study;
• Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day);
• Willingness to participate in the trial for up to 12 months without contact lens wear;
• The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.

You may not qualify if…

• Known allergy to proparacaine, tetracaine, or tropicamide.

Where it is running

• Golden Optometric Group — Whittier, California, United States
• Omega Vision Center PA — Longwood, Florida, United States
• Kannarr Eye Care — Pittsburg, Kansas, United States
• Advanced Eyecare PC — Raytown, Missouri, United States
• Sacco Eye Group — Vestal, New York, United States
• Total Eye Care — Memphis, Tennessee, United States
• Vision Optique — Houston, Texas, United States
• William J Bogus, OD, FAAO — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.